Literature DB >> 15799969

Nuclear targeting of transforming growth factor-beta-activated Smad complexes.

Hong Bing Chen1, Jonathan G Rud, Kai Lin, Lan Xu.   

Abstract

Upon stimulation by the transforming growth factor beta (TGF-beta), Smad2 and Smad3 are phosphorylated at their C termini and assemble into stable heteromeric complexes with Smad4. These complexes are the functional entities that translocate into the nucleus and regulate the expression of TGF-beta target genes. Here we report that the TGF-beta-activated phospho-Smad3/Smad4 complex utilizes an importin-independent mechanism for nuclear import and engages different nucleoporins for nuclear import compared with the monomeric Smad4. Within the heteromeric complex, phospho-Smad3 appears to dominate over Smad4 in the nuclear import process and guides the complex to its nuclear destination. We also demonstrate that the binding of phospho-Smad3 to Smad4 prevents Smad4 from interacting with the nuclear export receptor chromosome region maintenance 1. In this way, TGF-beta signaling suppresses nuclear export of Smad4 by chromosome region maintenance 1 and thereby targets Smad4 into the nucleus. Indeed tumorigenic mutations in Smad4 that affect its interaction with Smad2 or Smad3 impair nuclear accumulation of Smad4 in response to TGF-beta.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15799969     DOI: 10.1074/jbc.M500362200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Cytokine-induced nuclear translocation of signaling proteins and their analysis using the inducible translocation trap system.

Authors:  Shella Saint Fleur; Hodaka Fujii
Journal:  Cytokine       Date:  2008-01-18       Impact factor: 3.861

2.  Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system.

Authors:  Bernhard Schmierer; Alexander L Tournier; Paul A Bates; Caroline S Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

3.  Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis.

Authors:  Jianfei Xue; Xia Lin; Wen-Tai Chiu; Yao-Hui Chen; Guanzhen Yu; Mingguang Liu; Xin-Hua Feng; Raymond Sawaya; René H Medema; Mien-Chie Hung; Suyun Huang
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

Review 4.  TGF-β Family Signaling in Tumor Suppression and Cancer Progression.

Authors:  Joan Seoane; Roger R Gomis
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-12-01       Impact factor: 10.005

Review 5.  Regulation of Smad activities.

Authors:  Lan Xu
Journal:  Biochim Biophys Acta       Date:  2006-11-15

6.  Nuclear import of serum response factor in airway smooth muscle.

Authors:  John F McConville; Darren J Fernandes; Jason Churchill; Samantha Dewundara; Paul Kogut; Shardul Shah; Gregory Fuchs; Dalius Kedainis; Shashi K Bellam; Nina M Patel; Joel McCauley; Nickolai O Dulin; Mahesh P Gupta; Stephen Adam; Yoshihiro Yoneda; Blanca Camoretti-Mercado; Julian Solway
Journal:  Am J Respir Cell Mol Biol       Date:  2010-12-03       Impact factor: 6.914

7.  Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer.

Authors:  Anne Serrao; Laura M Jenkins; Alexander A Chumanevich; Ben Horst; Jiaxin Liang; Michael L Gatza; Nam Y Lee; Igor B Roninson; Eugenia V Broude; Karthikeyan Mythreye
Journal:  Oncogene       Date:  2018-05-21       Impact factor: 9.867

Review 8.  TGF-β Signaling from Receptors to Smads.

Authors:  Akiko Hata; Ye-Guang Chen
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

Review 9.  Decoding the quantitative nature of TGF-beta/Smad signaling.

Authors:  David C Clarke; Xuedong Liu
Journal:  Trends Cell Biol       Date:  2008-08-15       Impact factor: 20.808

10.  Preferential utilization of Imp7/8 in nuclear import of Smads.

Authors:  Xiaohao Yao; Xiaochu Chen; Charisa Cottonham; Lan Xu
Journal:  J Biol Chem       Date:  2008-06-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.